Gamida Cell to Present at Upcoming Conferences
Gamida Cell Ltd. (Nasdaq: GMDA), focused on advanced cell therapy for blood cancers, announced CEO Julian Adams will present at two virtual conferences in December 2020. The events are the Evercore ISI 3rd Annual HealthCONx Conference on December 3 at 12:10 p.m. ET, and the Piper Sandler 32nd Annual Healthcare Conference from December 1-3, where the fireside chat will be on-demand. Webcasts will be accessible in the Investors & Media section of their website for at least 14 days following each event.
- None.
- None.
BOSTON--(BUSINESS WIRE)--Gamida Cell Ltd. (Nasdaq: GMDA), an advanced cell therapy company committed to cures for blood cancers and serious blood diseases, today announced that Julian Adams, Chief Executive Officer of Gamida Cell, will present at two virtual conferences in December:
- Evercore ISI 3rd Annual HealthCONx Conference, fireside chat at 12:10 p.m. ET on December 3, 2020
- Piper Sandler 32nd Annual Healthcare Conference, on December 1st-3rd, 2020. Company fireside chat will be available to view on-demand throughout the duration of the conference.
A webcast of each presentation will be available in the “Investors & Media” section of the Gamida Cell website, www.gamida-cell.com, and will be available for at least 14 days following the event.
About Gamida Cell
Gamida Cell is an advanced cell therapy company committed to cures for patients with blood cancers and serious blood diseases. We harness our cell expansion platform to create therapies with the potential to redefine standards of care in areas of serious medical need. For additional information, please visit www.gamida-cell.com or follow Gamida Cell on LinkedIn or Twitter at @GamidaCellTx.